Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...

Top Swiss officials will this week test whether big commitments to the U.S. can help secure relief from import tariffs, after ...

Two of Europe’s biggest drugmakers said they’re looking at ways to protect themselves from US President Donald Trump’s ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...

The investment plans include new R&D sites in four US states and creating more than 12,000 jobs, according to the Swiss ...

The Swiss pharma giant said the new positions would include nearly 6,500 in construction and 1,000 at new and expanded ...

The United States is a key market for the pharmaceutical industry, representing more than half of the revenue of Roche's ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...

FRANKFURT (Reuters) -Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by ...